Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Ganitumab and metformin plus standard neoadjuvant therapy in stage 2/3 breast cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Ganitumab and metformin plus standard neoadjuvant therapy in stage 2/3 breast cancer.
Ganitumab and metformin plus standard neoadjuvant therapy in stage 2/3 breast cancer. NPJ Breast Cancer. 2021 Oct 05; 7(1):131.
View in:
PubMed
authors with profiles
Rita Nanda